Palavra-chave: AUTOLOGOUS STEM CELL TRANSPLANTATION

ADVANCED MULTIPLE MYELOMA HIGH DOSE SEQUENTIAL HODGKINS LYMPHOMA DATA META-ANALYSIS HODGKIN LYMPHOMA NON HODGKIN LYMPHOMA MULTIPLE MYELOMA DEXAMETHASONE RITUXIMABE RETROSPECTIVE STUDY INTERNATIONAL MYELOMA WORKING GROUP HIGH DOSE CHEMOTHERAPY EBMT HODGKIN S LYMPHOMA RANDOMIZED STUDY REFRACTORY LYMPHOMAS THALIDOMIDE 462 PATIENTS CHEMO-RADIOTHERAPY SALVAGE APPROACHES CD34+ PROGRESSION-FREE SURVIVAL NON-HODGKIN´S LYMPHOMA NON-HODGKIN´S LYMPHOMAS RELAPSE B CELL LYMPHOMA HIGH DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY THALIDOMIDE DEXAMETHASONE